NIH Weekly Funding Opportunities and Policy Notices

Tuesday, February 20, 2018 - 10:54am
Funding Opportunity PA-18-673 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support students at institutions without formal NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g., DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Applicants must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individuals potential to develop into a productive, independent physician/clinician-scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Tuesday, February 20, 2018 - 8:35am
Funding Opportunity PA-18-672 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Tuesday, February 20, 2018 - 8:13am
Notice NOT-MH-18-023 from the NIH Guide for Grants and Contracts
Tuesday, February 20, 2018 - 8:04am
Notice NOT-OD-18-133 from the NIH Guide for Grants and Contracts
Tuesday, February 20, 2018 - 12:09am
Funding Opportunity RFA-OD-18-004 from the NIH Guide for Grants and Contracts. The ORWH and participating organizations and institutes seek applications for Specialized Centers of Research Excellence (SCORE) on Sex Differences. The Centers of Excellence will support interdisciplinary approaches to advance translational research on sex differences. Each SCORE institution should develop a research agenda bridging basic and clinical research underlying a health issue that is pertinent to improving the health of women.
Friday, February 16, 2018 - 10:48am
Funding Opportunity PA-18-671 from the NIH Guide for Grants and Contracts. The purpose of the Kirschstein-NRSA predoctoral fellowship (F31) award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the applicants dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Friday, February 16, 2018 - 10:28am
Funding Opportunity PA-18-668 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support students at institutions with NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Applicants must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor
Friday, February 16, 2018 - 9:09am
Funding Opportunity RFA-RM-18-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the second phase of the NIH National Research Mentoring Network (NRMN) efforts. The NRMN is a nationwide consortium that was designed to enhance mentoring and career development of individuals from groups underrepresented in the biomedical research workforce. This new cycle of NRMN will expand the scientific scope of the program to encourage grants with varied approaches aimed at the science of mentorship, networking, and navigating critical career transition points. The NRMN will be a set of cooperative agreements in which the Program Directors/Principal Investigators (PDs/PIs) will work through a NRMN Coordination Center and the NRMN Resource Center to disseminate effective resources. The NRMN research is expected to align with the hallmarks of success that have been defined by the Diversity Program Consortium and the Center for Evaluation and Coordination (CEC).
Friday, February 16, 2018 - 9:09am
Funding Opportunity RFA-RM-18-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from qualified institutions for the NIH National Research Mentoring Network (NRMN) Resource Center. The NRMN is a nationwide consortium intended to enhance the training and career development of biomedical researchers from diverse backgrounds, through enhanced networking and mentorship experiences. One grant will be awarded for the development and management of a NRMN Resource Center, which will provide a web-based mentoring tool to facilitate real-time mentor/mentee engagement and networking. The awardee will also oversee the management of the NRMN website, report on outputs from NRMN components, and serve as a repository for publicly available mentoring resources and tools.
Friday, February 16, 2018 - 9:09am
Funding Opportunity RFA-RM-18-003 from the NIH Guide for Grants and Contracts. The National Research Mentoring Network (NRMN) is a nationwide consortium developed to enhance the training and career development of individuals from diverse backgrounds who are pursuing biomedical research careers by providing networking and mentorship experiences. The NRMN Coordination Center will provide infrastructure and expertise that supports the collection, secure storage, and reporting of data generated by the individual NRMN component projects. Building upon the instruments and processes developed to assess the impact of NRMN activities in the previous Diversity Program Consortium (DPC) funding period, the NRMN Coordination Center will coordinate the early stages of collection of data in an ongoing way, and provide feedback to the consortium to maximize the research benefit of the various NRMN activities. The NRMN Coordination Center will also be responsible for promoting synergistic interactions with the DPC Center for Evaluation and Coordination (CEC) for the long-term collection and storage of data.
Thursday, February 15, 2018 - 11:21pm
Notice NOT-AI-18-019 from the NIH Guide for Grants and Contracts
Thursday, February 15, 2018 - 11:18pm
Funding Opportunity PA-18-670 from the NIH Guide for Grants and Contracts. The purpose of the Kirschstein-NRSA postdoctoral fellowship is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Thursday, February 15, 2018 - 10:43am
Notice NOT-AI-18-018 from the NIH Guide for Grants and Contracts
Thursday, February 15, 2018 - 10:37am
Notice NOT-NS-18-043 from the NIH Guide for Grants and Contracts
Thursday, February 15, 2018 - 10:03am
Notice NOT-NR-18-008 from the NIH Guide for Grants and Contracts
Thursday, February 15, 2018 - 9:58am
Funding Opportunity RFA-DK-18-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective cell replacement therapies for type 1 diabetes (T1D). The purpose is to support research leading to the development and testing of novel and supportive technologies for the improvement of cell replacement interventions using novel biomaterials and devices for T1D treatment.
Thursday, February 15, 2018 - 9:38am
Funding Opportunity RFA-FD-18-005 from the NIH Guide for Grants and Contracts. The Food and Drug Administration (FDA), Office of Regulatory Affairs (ORA), Office of Training Education and Development (OTED) is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement Grant. The goals of this Cooperative Agreement Grant are to continue the development of the Integrated Food Safety System (IFSS) National Curriculum Standard (NCS) for the laboratory competency and curriculum frameworks, further work on the development and validation of competency statements. As the NCS is completed at each level, then training content can be developed to meet the standard, post web courses and deliver classroom courses to IFSS laboratorians nationwide. Under FSMA Section 209, FDA is directed to improve the training of state, local, territorial and tribal food safety officials and set standards and administer training and education programs to ensure a competent work force doing comparable work.
Thursday, February 15, 2018 - 9:32am
Funding Opportunity PAR-18-665 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support clinical trials for projects that were previously funded by NIH SBIR and STTR Phase II awards. The projects must focus on products related to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS) and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Since conducting the clinical trials needed for commercialization may be capital-intensive, the FOA aims to facilitate the transition of SBIR Phase II projects to the commercialization stage by promoting partnerships between NIHs SBIR/STTR awardees and third-party investors and/or strategic partners. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all SBIR Phase II applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will equal or exceed the NINDS funds being requested throughout the SBIR Phase IIB project period.

Pages